Company intelligence / Profile preview

Seltzer

New York, New York, United States

Ownership: Private
Employees: ~20
Development stage: Other

Overview

Seltzer is a clinical trial technology company that leverages artificial intelligence and advanced data analytics to streamline the drug development process. Founded by veterans from Flatiron Health and Google Health, the company focuses on optimizing patient recruitment and site selection for clinical trials. Its platform integrates diverse healthcare data sources to identify eligible patient populations more efficiently and accurately than traditional methods. By reducing the time and cost associated with trial enrollment, Seltzer aims to accelerate the delivery of life-saving therapies to patients.

Industry: Biomedical IT and Biomedical Data Platforms

Beyond the preview

Go deeper on Seltzer.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Seltzer.

Explore the full profile